Global Cardiac POC Testing Devices Market 2019-2023

The global cardiac POC testing devices market size will grow by USD 379.26 million during 2019-2023. This market report provides a detailed analysis of the market by end-users (hospitals and laboratories, diagnostic centers, and ambulatory centers and physicians' clinics) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on many market vendors, including Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., and Siemens Healthcare GmbH.

Some of the key findings from our cardiac POC testing devices market analysis report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Cardiac POC Testing Devices Industry Overview

Cardiovascular diseases (CVDs) are rising at an alarming rate because of the prevalence of high-risk factors such as diabetes, high cholesterol levels, smoking, sedentary lifestyle, and others. The growing disposable income and availability of health insurance and reimbursement policies are allowing individuals with CVDs to access diagnostic services and treatment. As a result, there is a growing popularity of equipment such as cardiac point-of-care (POC) testing devices. Moreover, its ability to assess blood glucose and cholesterol levels rapidly has also increased its adoption rate. The results are further assessed by healthcare practitioners to identify the risk of patients in CVDs. The disease burden of CVDs is high in countries in Europe and China. The high incidence of CVDs will increase the sales of diagnostic devices such as POC testing devices, which will propel the cardiac point of care testing devices market growth at a CAGR over 8% during 2019-2023.

Vendors have been focusing on improving the features and functionalities of cardiac POC testing devices to increase sales. For instance, laboratory functions are implemented in the majority of portable testing devices, increasing test menus. This feature allows end-users to quantify living cells anytime and anywhere. As a result, hospitals and clinics are switching from conventional testing methods to POC testing. Moreover, technology providers are leveraging on the popularity of these devices and have been manufacturing sensors, microsystems, and low-cost imaging techniques to enhance their functionalities. Technological advances in diagnostics is one of the key cardiac POC testing devices market trends, which will have a positive influence on the market over the forecast period.

Top Cardiac POC Testing Devices Companies Covered in this Market Research Report

The global cardiac POC testing devices market is moderately concentrated. To help clients improve their market positions, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. This cardiac POC testing devices market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several leading cardiac POC testing devices manufacturers, including:

• Abbott Laboratories
• bioMérieux SA
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Siemens Healthcare GmbH.

Cardiac POC Testing Devices Market Segmentation Based on End-users

• Hospitals and laboratories
• Diagnostic centers
• Ambulatory centers and physicians' clinics

Hospitals and laboratories held the largest market share in 2018 and will account for the highest global cardiac POC testing devices market share over the forecast period as well. High inflow of patients, expanding the use of medical devices, and growing healthcare expenditure are expected to boost the growth of the market segment during the forthcoming years. This report provides an accurate prediction of the contribution of all the segments to the growth of the cardiac POC testing devices market size.

Cardiac POC Testing Devices Market Segmentation Based on Geographic Region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the cardiac POC testing devices market throughout the forecast period. Factors such as the high-risk factors for CVDs such as smoking and diabetes and the rising awareness about cardiac-related diseases are contributing to the cardiac POC testing devices market growth in the region.

Key Highlights of the Global Cardiac POC Testing Devices Market Forecast Report for the Period 2019-2023

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the cardiac POC testing devices market during the next five years
• Precise estimation of the global cardiac POC testing devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the cardiac POC testing devices industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of cardiac POC testing devices companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch